# REC2Stim as a Treatment for Refractory Epilepsy in the Primary Sensorimotor Cortex.

> **NCT04158531** · NA · UNKNOWN · sponsor: **UMC Utrecht** · enrollment: 10 (estimated)

## Conditions studied

- Epileptic Seizure
- Epilepsy Intractable
- Motor Seizure

## Interventions

- **DEVICE:** ECoG sensing and stimulation

## Key facts

- **NCT ID:** NCT04158531
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-04
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-07-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2019-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04158531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04158531, "REC2Stim as a Treatment for Refractory Epilepsy in the Primary Sensorimotor Cortex.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04158531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*